Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Patanase in pediatric allergic rhinitis
NCT00794144Phase 2Completed
- Sponsor
- Alcon Inc.
- Start
- Oct 2008
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in allergic rhinitis (AR) comparing Patanase with Placebo (2 arms). Primary endpoint: Number of Participants With Anatomic Nasal Exam Abnormalities. Started Oct 2008; status: completed.
02
Drugs
olopatadine
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT00794144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00794144.